🟢 Ultragenyx is trading 4.3% up today amid broad market strength and biotech sector gains

Ultragenyx is trading at $26.07 (up 4.3%) amid a broad risk-on move in U.S. equities and strength in biotech peers.

• The stock appears to be rebounding from recent weakness alongside the sector rather than on any new, company-specific catalyst.
• The move follows a broader market rally, with the S&P 500 and Nasdaq both gaining more than 1.5%.
• Sector-specific strength is also providing a tailwind, as the XBI biotech ETF has risen approximately 2%.